ABCL
Price
$5.63
Change
-$0.10 (-1.74%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
1.72B
44 days until earnings call
Intraday BUY SELL Signals
TLSA
Price
$1.16
Change
-$0.00 (-0.00%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
146.98M
Intraday BUY SELL Signals
Interact to see
Advertisement

ABCL vs TLSA

ABCL vs TLSA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ABCL vs. TLSA commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Hold and TLSA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 24, 2026
Stock price -- (ABCL: $5.74 vs. TLSA: $1.14)
Brand notoriety: ABCL and TLSA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 68% vs. TLSA: 66%
Market capitalization -- ABCL: $1.75B vs. TLSA: $145.08M
ABCL [@Biotechnology] is valued at $1.75B. TLSA’s [@Biotechnology] market capitalization is $145.08M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileTLSA’s FA Score has 0 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • TLSA’s FA Score: 0 green, 5 red.
According to our system of comparison, ABCL is a better buy in the long-term than TLSA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 5 TA indicator(s) are bullish while TLSA’s TA Score has 4 bullish TA indicator(s).

  • ABCL’s TA Score: 5 bullish, 3 bearish.
  • TLSA’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ABCL is a better buy in the short-term than TLSA.

Price Growth

ABCL (@Biotechnology) experienced а +9.13% price change this week, while TLSA (@Biotechnology) price change was +2.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.89%. For the same industry, the average monthly price growth was +2.09%, and the average quarterly price growth was +1952.22%.

Reported Earning Dates

ABCL is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Biotechnology (+5.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($1.72B) has a higher market cap than TLSA($147M). ABCL YTD gains are higher at: 67.836 vs. TLSA (-23.490). TLSA has higher annual earnings (EBITDA): -17.14M vs. ABCL (-167.02M). ABCL has more cash in the bank: 505M vs. TLSA (201K). TLSA has less debt than ABCL: TLSA (247K) vs ABCL (140M). ABCL has higher revenues than TLSA: ABCL (79.2M) vs TLSA (0).
ABCLTLSAABCL / TLSA
Capitalization1.72B147M1,169%
EBITDA-167.02M-17.14M975%
Gain YTD67.836-23.490-289%
P/E RatioN/AN/A-
Revenue79.2M0-
Total Cash505M201K251,244%
Total Debt140M247K56,680%
FUNDAMENTALS RATINGS
TLSA: Fundamental Ratings
TLSA
OUTLOOK RATING
1..100
52
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
77
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABCLTLSA
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 29 days ago
82%
Declines
ODDS (%)
Bearish Trend 14 days ago
82%
Bearish Trend 12 days ago
89%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
77%
Aroon
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ABCL
Daily Signal:
Gain/Loss:
TLSA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
QISCX33.65N/A
N/A
Federated Hermes MDT Small Cap Core IS
ECOIX11.20N/A
N/A
Redwheel Next Generation Power InfrasIns
ALCEX19.35N/A
N/A
Avantis U.S. Large Cap Value G
WCPSX40.51N/A
N/A
Communication Services UltraSectorProSvc
JAGIX79.29-0.25
-0.31%
Janus Henderson Growth And Income T

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with RXRX. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
+3.80%
RXRX - ABCL
60%
Loosely correlated
-2.01%
CRSP - ABCL
56%
Loosely correlated
+0.50%
PRME - ABCL
56%
Loosely correlated
+4.33%
VCYT - ABCL
56%
Loosely correlated
-0.82%
ABSI - ABCL
54%
Loosely correlated
+13.50%
More

TLSA and

Correlation & Price change

A.I.dvisor tells us that TLSA and CTMX have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TLSA and CTMX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TLSA
1D Price
Change %
TLSA100%
-1.72%
CTMX - TLSA
28%
Poorly correlated
+2.88%
IMTX - TLSA
27%
Poorly correlated
N/A
ABCL - TLSA
26%
Poorly correlated
+3.80%
KROS - TLSA
26%
Poorly correlated
+3.19%
ABOS - TLSA
25%
Poorly correlated
+5.53%
More